|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product revenue | |||||
| Other revenue | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Cost of sales - product | |||||
| Total cost of sales - product | |||||
| Cost of sales - amortization of intangible assets | |||||
| Total cost of sales - amortization of intangible assets | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Gain on sale of assets (Note 8) | |||||
| Bad debt expense (Note 9) | |||||
| Total operating expenses | |||||
| (Loss) income from operations | |||||
| Other (expense) income: | |||||
| Interest income | |||||
| Interest expense | |||||
| Sublease income | |||||
| Loss on debt extinguishment (Note 11) | |||||
| Change in fair value of warrant liability (Note 14) | |||||
| Other | |||||
| Net income (loss) before income taxes | |||||
| Provision for income taxes | |||||
| Net income (loss) | |||||
| Undistributed earnings allocated to participating securities | |||||
| Net (loss) income allocable to common stockholders, basic (in USD per share) | |||||
| Net income (loss) per share allocable to common stockholders | |||||
| Basic (in USD per share) | |||||
| Diluted (in USD per share) | |||||
| Weighted-average shares used in computing net income (loss) per share allocable to common stockholders: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...